Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

Nature Medicine volume 1, pages 464–470 (1995)Cite this article

Abstract

HLA-restricted cytotoxic T-lymphocyte (CTL) recognition of human papillomavirus (HPV) oncogene products may be important in the control of the HPV infections associated with the development of cervical cancer. We have identified, in HLA-B7 individuals, a consistent variation in the HPV16 E6 oncoprotein sequence, which alters an HLA-B7 peptide binding epitope in a way likely to influence immune recognition by CTLs. These results illustrate a biologically relevant mechanism for escape from immune surveillance of HPV16 in HLA-B7 individuals. Thus, both HLA type and HPV16 strain variation need to be considered in the screening of at-risk individuals and for the rational design of anti-HPV vaccines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Zur Hausen, H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology 184, 9–13 (1991).

    Article  CAS  Google Scholar 

  2. Koutsky, L.A. et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New Engl. J. Med. 327, 1272–1278 (1992).

    Article  CAS  Google Scholar 

  3. Lorincz, A.T. et al. Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. Am. J. obstet. Gynecol. 162, 645–651 (1990).

    Article  CAS  Google Scholar 

  4. Brinton, L.A. Epidemiology of cervical cancer — overview. in Epidemiology of Cervical Cancer and Human Papillomavirus (eds Munoz, N., Bosch, F. X., Shah, K. V. & Meheus, A.) 3–23 (IARC, Lyon, 1992).

    Google Scholar 

  5. Wank, R. & Thomssen, C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352, 723–725 (1991).

    Article  CAS  Google Scholar 

  6. Glew, S.S., Stern, P.L., Davidson, J.A. & Dyer, P.A. HLA antigens and cervical carcinoma. Nature 356, 22 (1992).

    Article  CAS  Google Scholar 

  7. Helland, Å., Børresen, A.L., Kaern, S., Rønningen, K.S. & Thorsby, E. HLA antigens and cervical carcinoma. Nature 356, 23 (1992).

    Article  CAS  Google Scholar 

  8. Han, R., Breitburd, F., Marche, P.N. & Orth, G. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature 356, 66–68 (1992).

    Article  CAS  Google Scholar 

  9. Apple, R.J. et al. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet. 6, 157–162 (1994).

    Article  CAS  Google Scholar 

  10. Pirisi, L., Yasumoto, S., Feller, M., Doniger, J. & DiPaolo, J.A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 61, 1061–1066 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Sadovnikova, E. et al. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein. Int. Immun. 6, 289–296 (1994).

    Article  CAS  Google Scholar 

  12. Townsend, A. et al. The epitopes of influenza nucleoprotein recognised by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959–968 (1986).

    Article  CAS  Google Scholar 

  13. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. & Rammensee, H-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290–296 (1991).

    Article  CAS  Google Scholar 

  14. Keating, P.J. et al. Frequency of downregulation of individual HLA-A and-B alleles in cervical carcinomas in relation to TAP-1 expression. Br. J. Cancer, (in the press).

  15. Honma, S. et al. Biological-clinical significance of selective loss of HLA-class-1 allelic product expression in squamous-cell carcinoma of the uterine cervix. Int. J. Cancer 57 650–655 (1994).

    Article  CAS  Google Scholar 

  16. Cerundolo, V. et al. Presentation of viral antigen controlled by a gene in the major histocompatability complex. Nature 345, 449–452 (1990).

    Article  CAS  Google Scholar 

  17. Elvin, J., Potter, C., Elliot, T., Cerundolo, V. & Townsend, A. A method to quantify binding of unlabelled peptides to Class 1 MHC molecules and detect their allele specificity. J. immunol. Methods 158, 161–171 (1993).

    Article  CAS  Google Scholar 

  18. Huczko, E.L. et al. Characteristics of endogenous peptides eluted from the class 1 MHC HLA-B7 determined by mass spectrometry and computer modelling. J. Immun. 151, 2572–2587 (1993).

    CAS  PubMed  Google Scholar 

  19. Maier, R. et al. Peptide motifs of HLA-A3,-A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40, 306–308 (1994).

    Article  CAS  Google Scholar 

  20. Engelhard, V.H. et al. Mass spectrometric analysis of peptides associated with the human class 1 MHC molecules HLA-A2. 1 and HLA-B7 and identification of structural features that determine binding. Chem. Immun. 57, 39–62 (1993).

    Article  CAS  Google Scholar 

  21. Bartholomew, J. et al. Identification of a naturally processed HLA-A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. Eur. J. Immunol. 24, 3175–3179 (1994).

    Article  CAS  Google Scholar 

  22. Crook, T., Tidy, J.A. & Vousden, K.H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67, 547–556 (1991).

    Article  CAS  Google Scholar 

  23. Klenerman, P. et al. Cytotoxic T-cell activity antagonized by naturally ocurring H1V-1 Gag variants. Nature 369, 403–407 (1994).

    Article  CAS  Google Scholar 

  24. Bertoletti, A. et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T-cells. Nature 369, 407–410 (1994).

    Article  CAS  Google Scholar 

  25. Gavioli, R. et al. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67 1572–1578 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Burrows, S.R., Sculley, T.B., Misko, I.S., Schmidt, C. & Moss, D.J. An Epstein-Barr virus specific cytotoxic T-cell epitope in EBV nuclear antigen 3 (EBNA 3). J. exp. Med. 171, 345–352 (1990).

    Article  CAS  Google Scholar 

  27. Phillips, R.E. et al. Human immunodeficency virus genetic variation that can escape cytotoxic T-cell recognition. Nature 354, 453–459 (1991).

    Article  CAS  Google Scholar 

  28. Hill, A.V.S. et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434–439 (1992).

    Article  CAS  Google Scholar 

  29. Madden, D.R., Gorga, J.C., Strominger, J.L. & Wiley, D.C. The three dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035–1048 (1992).

    Article  CAS  Google Scholar 

  30. Ellis, S.A., Taylor, C. & McMichael, A. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum. Immun. 5, 49–59 (1982).

    Article  CAS  Google Scholar 

  31. Hill, A. et al. Characterisation of two Epstein-Barr virus epitopes restricted by HLA-B7. Eur. J. Immun. 25, 18–24 (1995).

    Article  CAS  Google Scholar 

  32. Barnstaple, C.J. et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human ceil surface antigens — new tools for genetic analysis. Cell 14, 9–20 (1978).

    Article  Google Scholar 

  33. Garrido, F. et al. Natural history of HLA expression during tumour development. Immun. Today 14, 491–499 (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Birmingham, CRC Institute for Cancer Studies, University of Birmingham Medical School, Birmingham, B15 2TJ, UK

    J.R.M. Ellis, J. Baird, M. Rowe, D. Hopkins & L.S. Young

  2. CRC Department of Immunology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 9BX, UK

    P.J. Keating, M.F. Duggan-Keen, J.S. Bartholomew & P.L. Stern

  3. Department of Biochemistry and Molecular Biology, University College London, Gower Street, London, WC1E 6BT, UK

    E. F. Hounsell & D. V. Renouf

Authors
  1. J.R.M. Ellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P.J. Keating
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Baird
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. F. Hounsell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. V. Renouf
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Rowe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Hopkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M.F. Duggan-Keen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J.S. Bartholomew
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. L.S. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P.L. Stern
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ellis, J., Keating, P., Baird, J. et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1, 464–470 (1995). https://doi.org/10.1038/nm0595-464

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0595-464

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing